Učitavanje...
Targeting mTOR in Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia (ALL) is an aggressive hematologic disorder and constitutes approximately 25% of cancer diagnoses among children and teenagers. Pediatric patients have a favourable prognosis, with 5-years overall survival rates near 90%, while adult ALL still correlates with poorer surv...
Spremljeno u:
| Izdano u: | Cells |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6406494/ https://ncbi.nlm.nih.gov/pubmed/30795552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells8020190 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|